Sign Up to like & get
recommendations!
0
Published in 2018 at "Epilepsy Research"
DOI: 10.1016/j.eplepsyres.2017.12.013
Abstract: PURPOSE Seizures in rare atypical and malignant meningiomas were significantly under-studied. Our aim was to examine the rates, predictors, and seizure control in these meningiomas, and to analyze associations between clinical characteristics and seizure free…
read more here.
Keywords:
meningiomas;
atypical malignant;
seizures surgically;
preoperative seizures ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Neuro-oncology"
DOI: 10.1093/neuonc/noab075
Abstract: BACKGROUND Malignant meningiomas are fatal and lack effective therapy. As M2 macrophages are the most prevalent immune cell type in human meningiomas, we hypothesized that normalizing this immunosuppressive population would be an effective treatment strategy.…
read more here.
Keywords:
treatment;
meningiomas;
malignant meningiomas;
csf1 csf1r ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2023.1157182
Abstract: Background The incidence of meningioma is disparate to sex: meningiomas are more common in women than in men, especially in middle-aged women. Understanding the epidemiology and survival of middle-aged women with meningiomas would help estimate…
read more here.
Keywords:
non malignant;
middle aged;
malignant meningiomas;
epidemiology ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Pathology and Oncology Research"
DOI: 10.3389/pore.2022.1610572
Abstract: Malignant meningiomas have a high mortality rate and short survival time and currently have no effective treatment. In our study, proteomics analysis was performed to identify highly expressed proteins as therapeutic targets in malignant meningiomas.…
read more here.
Keywords:
immunotherapy;
pp2a;
meningiomas;
sensitivity malignant ... See more keywords